Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.

Chang AY, Dao T, Gejman RS, Jarvis CA, Scott A, Dubrovsky L, Mathias MD, Korontsvit T, Zakhaleva V, Curcio M, Hendrickson RC, Liu C, Scheinberg DA.

J Clin Invest. 2017 Sep 1;127(9):3557. doi: 10.1172/JCI96860. Epub 2017 Sep 1. No abstract available.

2.

A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.

Chang AY, Dao T, Gejman RS, Jarvis CA, Scott A, Dubrovsky L, Mathias MD, Korontsvit T, Zakhaleva V, Curcio M, Hendrickson RC, Liu C, Scheinberg DA.

J Clin Invest. 2017 Jun 30;127(7):2705-2718. doi: 10.1172/JCI92335. Epub 2017 Jun 19. Erratum in: J Clin Invest. 2017 Sep 1;127(9):3557.

3.

An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules.

Dao T, Korontsvit T, Zakhaleva V, Jarvis C, Mondello P, Oh C, Scheinberg DA.

Oncoimmunology. 2016 Dec 7;6(2):e1252895. doi: 10.1080/2162402X.2016.1252895. eCollection 2017.

4.

Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.

Dao T, Pankov D, Scott A, Korontsvit T, Zakhaleva V, Xu Y, Xiang J, Yan S, de Morais Guerreiro MD, Veomett N, Dubrovsky L, Curcio M, Doubrovina E, Ponomarev V, Liu C, O'Reilly RJ, Scheinberg DA.

Nat Biotechnol. 2015 Oct;33(10):1079-86. doi: 10.1038/nbt.3349. Epub 2015 Sep 21.

5.

Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein.

Veomett N, Dao T, Liu H, Xiang J, Pankov D, Dubrovsky L, Whitten JA, Park SM, Korontsvit T, Zakhaleva V, Casey E, Curcio M, Kharas MG, O'Reilly RJ, Liu C, Scheinberg DA.

Clin Cancer Res. 2014 Aug 1;20(15):4036-46. doi: 10.1158/1078-0432.CCR-13-2756. Epub 2014 May 21.

6.

Targeting the intracellular WT1 oncogene product with a therapeutic human antibody.

Dao T, Yan S, Veomett N, Pankov D, Zhou L, Korontsvit T, Scott A, Whitten J, Maslak P, Casey E, Tan T, Liu H, Zakhaleva V, Curcio M, Doubrovina E, O'Reilly RJ, Liu C, Scheinberg DA.

Sci Transl Med. 2013 Mar 13;5(176):176ra33. doi: 10.1126/scitranslmed.3005661.

7.

Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens.

Villa CH, Dao T, Ahearn I, Fehrenbacher N, Casey E, Rey DA, Korontsvit T, Zakhaleva V, Batt CA, Philips MR, Scheinberg DA.

ACS Nano. 2011 Jul 26;5(7):5300-11. doi: 10.1021/nn200182x. Epub 2011 Jun 23.

8.

WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer.

Krug LM, Dao T, Brown AB, Maslak P, Travis W, Bekele S, Korontsvit T, Zakhaleva V, Wolchok J, Yuan J, Li H, Tyson L, Scheinberg DA.

Cancer Immunol Immunother. 2010 Oct;59(10):1467-79. doi: 10.1007/s00262-010-0871-8. Epub 2010 Jun 8.

9.

Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.

Maslak PG, Dao T, Krug LM, Chanel S, Korontsvit T, Zakhaleva V, Zhang R, Wolchok JD, Yuan J, Pinilla-Ibarz J, Berman E, Weiss M, Jurcic J, Frattini MG, Scheinberg DA.

Blood. 2010 Jul 15;116(2):171-9. doi: 10.1182/blood-2009-10-250993. Epub 2010 Apr 16.

10.

Identification of a human cyclin D1-derived peptide that induces human cytotoxic CD4 T cells.

Dao T, Korontsvit T, Zakhaleva V, Haro K, Packin J, Scheinberg DA.

PLoS One. 2009 Aug 25;4(8):e6730. doi: 10.1371/journal.pone.0006730.

11.

Non-natural and photo-reactive amino acids as biochemical probes of immune function.

Gómez-Nuñez M, Haro KJ, Dao T, Chau D, Won A, Escobar-Alvarez S, Zakhaleva V, Korontsvit T, Gin DY, Scheinberg DA.

PLoS One. 2008;3(12):e3938. doi: 10.1371/journal.pone.0003938. Epub 2008 Dec 15.

12.

A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease.

Maslak PG, Dao T, Gomez M, Chanel S, Packin J, Korontsvit T, Zakhaleva V, Pinilla-Ibarz J, Berman E, Scheinberg DA.

Leukemia. 2008 Aug;22(8):1613-6. doi: 10.1038/leu.2008.7. Epub 2008 Feb 7. No abstract available.

PMID:
18256684
13.

Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.

May RJ, Dao T, Pinilla-Ibarz J, Korontsvit T, Zakhaleva V, Zhang RH, Maslak P, Scheinberg DA.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4547-55. Erratum in: Clin Cancer Res. 2007 Sep 1;13(17):5226.

14.

Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein.

Pinilla-Ibarz J, May RJ, Korontsvit T, Gomez M, Kappel B, Zakhaleva V, Zhang RH, Scheinberg DA.

Leukemia. 2006 Nov;20(11):2025-33. Epub 2006 Aug 31.

PMID:
16990779
15.

Natural killer cells license dendritic cell cross-presentation of B lymphoma cell--associated antigens.

Dao T, Gomez-Nunez M, Antczak C, Kappel B, Jaggi JS, Korontsvit T, Zakhaleva V, Scheinberg DA.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8763-72.

16.

Synthetic peptide analogs derived from bcr/abl fusion proteins and the induction of heteroclitic human T-cell responses.

Pinilla-Ibarz J, Korontsvit T, Zakhaleva V, Roberts W, Scheinberg DA.

Haematologica. 2005 Oct;90(10):1324-32.

17.

A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia.

Cathcart K, Pinilla-Ibarz J, Korontsvit T, Schwartz J, Zakhaleva V, Papadopoulos EB, Scheinberg DA.

Blood. 2004 Feb 1;103(3):1037-42. Epub 2003 Sep 22.

PMID:
14504104
18.

[Contamination of fish tissue cell cultures by Mycoplasma].

Rakovskaia IV, Zakhaleva VA, Khodakova LP, Marantidi AN.

Vestn Akad Med Nauk SSSR. 1991;(6):49-51. Russian.

PMID:
1927041
19.

[Ultrastructural characteristics of Proteus vulgaris and Proteus mirabilis cells differing in the capacity for swarming].

Bondarenko VM, Gosteva VV, Klitaunova NV, Zakhaleva VA, Gabidullin ZG.

Zh Mikrobiol Epidemiol Immunobiol. 1987 Jan;(1):3-6. Russian.

PMID:
3551413
20.

[Ultrastructural characteristics of a focus of recurrent infection in genital herpes patients (clinical and electron microscopy studies)].

Kalamkarian AA, Delektorskiĭ VV, Grebeniuk VN, Masiukova SA, Zakhaleva VA.

Vopr Virusol. 1983 Jan-Feb;28(1):91-6. Russian.

PMID:
6303000
21.

[Local immunity in patients with herpes genitalis (clinical and electron microscope study)].

Kalamkarian AA, Delektorskiĭ VV, Grebeniuk VN, Masiukova SA, Zakhaleva VA.

Vestn Dermatol Venerol. 1982 Apr;(4):4-7. Russian. No abstract available.

PMID:
6283762
22.

[Production of noninfectious virions of the Rous sarcoma virus by virogenic hamster cells].

Cherepantseva EA, Zakharova LG, Zakhaleva VA, Shevliagin VIa.

Vopr Virusol. 1981 Jul-Aug;(4):485-8. Russian.

PMID:
6171103
23.

[Action of aurantin on the chromosomal structure of continuous cultures of human amniotic cells (line A-1)].

Suskova VS, Suskov II, Serebriakov NG, Bliumkin VN, Zakhaleva VA.

Antibiotiki. 1975 Aug;20(8):698-701. Russian.

PMID:
59574
24.

[Morphogenesis of a virus similar to foamy agent].

Zakhaleva VA.

Vopr Virusol. 1974 Jan-Feb;(1):91-4. Russian. No abstract available.

PMID:
4374818
25.

[Morphogenesis of type A oncornaviruses in dividing cells].

Zakhaleva VA, Gorokhova LV.

Vopr Virusol. 1973 May-Jun;18(3):370-2. Russian. No abstract available.

PMID:
4358710
26.

[Morphology of type A, B, and C oncornaviruses of continuous human and animal cell lines].

Bykovskii AF, Miller GG, Klitsunova NV, Gorokhova LV, Zakhaleva VA.

Vopr Virusol. 1973 Mar-Apr;18(2):215-21. Russian. No abstract available.

PMID:
4196173

Supplemental Content

Loading ...
Support Center